Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
8S(9R)-EET is an oxylipin and a metabolite of arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607).1 It is formed via oxidation of arachidonic acid by the cytochrome P450 (CYP) isoforms CYP1A1, CYP1A2, CYP2B1, and CYP2B2. 8S(9R)-EET induces relaxation of precontracted isolated dog epicardial arterioles (EC50 = 121 pM).2 Intrarenal infusion of 8S(9R)-EET (0.5, 1, or 2 µg/kg per minute) induces glomerular vasoconstriction and reduces the glomerular filtration rate in rats.3
WARNING This product is not for human or veterinary use.
1. Cytochrome P-
2. EET homologs potently dilate coronary microvessels and activate BKCa channels. Am. J. Physiol. Heart Circ. Physiol. 280(6), H2430-H2440 (2001).
3. Glomerular stereospecific synthesis and hemodynamic actions of 8,9-